Diseases that progressively destroy nerve cells in the brain or spinal cord, such as Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), are devastating conditions with no cures.
Now, a team
that includes a University of Iowa researcher has identified a new class
of small molecules, called the P7C3 series, which block cell death in
animal models of these forms of neurodegenerative disease. The P7C3
series could be a starting point for developing drugs that might help
treat patients with these diseases. These findings are reported in two
new studies published the week of Oct. 1 in PNAS Early Edition.
More info here: http://bit.ly/PMe3Tp